As per the Economic Survey, India's research & development (R&D) and innovation capabilities have been ranked lower than those of other BRICS nations - mainly Brazil, Russia and China. And this too, despite having better scientific research institutions! It is also pointed out that despite having better market knowledge, technology and creativity, the country ranks poorly when it comes to other metrics. These include institutional support, human resources, research infrastructure and business sophistication.
India recently topped the list of highest growth in R&D investments during 2012. Such investments by Indian companies were higher by over 35% from a year ago. China ranked second with a growth of over 28%. But while India's topped this chart, it must be noted that the amounts in absolute terms are considered to be quite meager. India's R&D spends stands at about 1% of its trillion dollar GDP. The point on the lack of human resource takes into account the quantum of people employed in the field of research. India's ranking on this parameter would be quite poor.
What also makes matters worse is that from the investments being made, a significant amount is not being turned into commercial ventures. Industry-university collaborations have also not yielded significant outputs, a model which works quite well in developed countries like the US.
Coming to what ultimately R&D is all about - patents - it is believed that the total number of applications filed in India stood at about 37,000 in 2011. Just to make a comparison, California filed for 30,750 patents in the same year.
While the numbers of R&D setups in the country have increased of late, to move higher up the value chain, long term plans need to be made. While investments in education or further incentivizing R&D efforts (such as tax benefits) are possibilities, India could also leverage its position as one having the capabilities and a fairly strong position in Asia of being the R&D hub for global companies looking to enter or expand in these parts of the world.
For information on how to pick stocks that have the potential to deliver big returns, download our special report now!
Read the latest Market Commentary
What else is happening in the markets today? Dig in...
MRPL share price has hit a 52-week high. It is presently trading at Rs 45. BSE 500 Index is up by 1.7% at 19,713. Within the BSE 500, MRPL (up 8.3%) and RCF (up 20.0%) are among the top gainers, while top losers are HIMADRI SPECIALITY CHEMICAL and BHARTI AIRTEL.
KEC INTERNATIONAL share price is trading up by 5% and its current market price is Rs 454. The BSE CAPITAL GOODS is up by 1.6%. The top gainers in the BSE CAPITAL GOODS Index are KEC INTERNATIONAL (up 5.2%) and BHARAT ELECTRONICS (up 6.5%). The top losers are SCHAEFFLER INDIA (down 0.2%) and HINDUSTAN AERO. (down 0.3%).
GUJARAT ALKALIES share price is trading up by 10% and its current market price is Rs 346. The BSE 500 is up by 1.6%. The top gainers in the BSE 500 Index are GUJARAT ALKALIES (up 10.2%) and DEEPAK NITRITE (up 14.5%). The top losers are COLGATE and HDFC AMC .
DEEPAK NITRITE share price is trading up by 13% and its current market price is Rs 1,553. The BSE 500 is up by 1.4%. The top gainers in the BSE 500 Index are DEEPAK NITRITE (up 12.8%) and JUST DIAL (up 14.2%). The top losers are BAJAJ HOLDINGS & INVESTMENT and CADILA HEALTHCARE .
HIMADRI SPECIALITY CHEMICAL share price is trading down by 11% and its current market price is Rs 55. The BSE 500 is up by 1.4%. The top gainers in the BSE 500 Index are RCF (up 20.0%) and MMTC (up 20.0%). The top losers is HIMADRI SPECIALITY CHEMICAL (down 11.3%).
BSE Sensex is trading up by 378 points, while the NSE Nifty is trading up by 165 points.
View More Indian Share Market NewsLast time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.
A look at what India's top equity mutual funds bought and sold in January 2021.
Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.
In this video, I'll show you how to get started on the path to daily trading profits.
More
Equitymaster requests your view! Post a comment on "Indian R&D: Only higher spends not enough". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!